# Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva

> **NCT01595061** · PHASE2 · UNKNOWN · sponsor: **Gynecologic Oncology Group** · enrollment: 57 (actual)

## Conditions studied

- Stage III Vulvar Cancer AJCC v7
- Stage IIIA Vulvar Cancer AJCC v7
- Stage IIIB Vulvar Cancer AJCC v7
- Stage IIIC Vulvar Cancer AJCC v7
- Stage IVA Vulvar Cancer AJCC v7
- Vulvar Squamous Cell Carcinoma

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Gemcitabine Hydrochloride
- **RADIATION:** Intensity-Modulated Radiation Therapy
- **PROCEDURE:** Therapeutic Conventional Surgery

## Key facts

- **NCT ID:** NCT01595061
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-07-02
- **Primary completion:** 2020-09-23
- **Final completion:** 2022-09-23
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2021-12-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01595061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01595061, "Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01595061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*